Vella - HW1

Vella - HW1

by Lea Vella -
Number of replies: 5

Gap of interest: Identification of Dementia in Primary Care

During Medicare enrollees’ Annual Wellness Visit, primary care physicians are asked by CMS to “detect cognitive impairment…by direct observation, with due consideration of information obtained via beneficiary reports and concerns raised by family members, friends, caretakers, or others.”1 However dementia, one of the more severe forms of cognitive impairment, remains undiagnosed in a large percentage of primary care samples.2 Screening tests (i.e., structured assessments), can assist detection of dementia, especially when informants are not available for questioning. While it is generally agreed that there is no gold standard for screening, physician reliance on routine history and physical examination is often not sufficient to properly diagnose dementia.2 The U.S. Preventative Services Task Force and the Alzheimer’s Association recommend the use of evaluation of signs/symptoms and the use of a structured assessment, in a step-wise-fashion.2-3 While we do not yet have strong interventions for dementia, early detection can lead to: (1) evaluation for reversible causes of memory loss, (2) allow time for patients and families prepare for future care (i.e., living arrangements, financial considerations, advanced directives, etc.).

It is not clear from current research exactly what the prevalence of structured assessment in primary care is, however, there are only a small number of cognitive screening tests that have been validated in primary care.3 Therefore, even if they are being used, it is likely that the most appropriate assessment may not be utilized. Ideally, screening for dementia would include an assessment of signs/symptoms of cognitive impairment followed by a structured assessment which as been validated in both primary care, and the specific demographic population that best represents the patient (i.e., age, race/ethnicity, language, education level). While there is no gold standard, there are a number of cognitive screening assessments (i.e., direct patient assessments and informant questionnaires) that can be adequately utilized in the primary care setting. Consequences of inadequate or improper assessment can lead to poor care outcomes for both the patient and practitioner (e.g., patient without capacity and no appointed DPOA for healthcare or finances).

 

1https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/AWV_chart_ICN905706.pdf (accessed 4/10/18)

 

2Boustani, M. et al., (2003) Screening for dementia in primary care: A summary of the evidence for the U.S. preventative services task force. Ann Intern Med, 138:927-937

3Cordell, C.B. et al (2013) Alzheimer’s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimer’s & Dementia, 9:141-150

In reply to Lea Vella

Re: Vella - HW1

by Lori -

Hi Lea,


Great topic, and an issue that will only become increasingly relevant as our population ages.


As PCPs are often tasked with conducting the initial screening for cognitive impairment, why have so few screening assessments been validated for use in primary care settings?


Additionally, you noted that currently there are a number of cognitive screeners that could be adequately utilized in primary care settings. If this is the case, what do you think are the main barriers to their implementation? 


Looking forward to hearing more about your topic!


Lori

In reply to Lea Vella

Re: Vella - HW1

by Karla Zurita -

Hi Lea,

Very interesting and an important gap to explore.

You note that not having a gold standard tool may contribute to the underdiagnosis of dementia.  Are there specific barriers that providers face in identifying or developing a gold standard? 

One aspect of exploring this gap is analyzing the currently available tools, themselves.  Have interrater and intrarater variability in the currently-available tools. Does one clearly stand out above others?  Is one more objective than the others?  Also, how long are they? Do time constraints play a role in how often the current tools are used?

The last thought is whether providers would respond well to a reward for completing each assessment.  Perhaps participating in a study to try to determine a goal-standard assessment for cognitive impairment is enough of an incentive.

Excited to hear more.
In reply to Lea Vella

Re: Vella - HW1

by Monica Ospina Romero -

Hi Lea,

This is a great topic. As you said before, a disease modifier drug is not available for dementia, but there are other interventions available to decrease the burden of this disease. However, dementia screening, as any other screening practice, can bring some negative unintended consequences, is there evidence that implementing dementia screening in primary care can bring potential harms to patients diagnosed with dementia?

In reply to Lea Vella

Re: Vella - HW1

by Andrea Pedroza Tobias -

Hi Lea, 

It is a relevant topic, now that the proportion of the old population is increasing. I am impressed about the high rates of undiagnosed dementia. Do you know what are the main barriers for dementia assessment or diagnosis? 

In reply to Lea Vella

Re: Vella - HW1

by Amy Gladin -

This is such an important topic.  Do you think lack of treatment options contributes to the lack of screening done? I would love to see a tool that is able identify potentially treatable impairments early in process if they exist?  I have to imagine early detection and treatment would help? I am curious about the combination of both cognitive and motor/physical function declines that happen concomitantly. Really looking forward to hearing about your project.